Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups

BACKGROUND: Current diagnostic blood tests for prostate cancer (PCa) are unreliable for the early stage disease, resulting in numerous unnecessary prostate biopsies in men with benign disease and false reassurance of negative biopsies in men with PCa. Predicting the risk of PCa is pivotal for making...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshaker, Heba, Mills, Robert, Hunter, Ewan, Salter, Matthew, Ramadass, Aroul, Skinner, Benjamin Matthew, Westra, Willem, Green, Jayne, Akoulitchev, Alexandre, Winkler, Mathias, Pchejetski, Dmitri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845038/
https://www.ncbi.nlm.nih.gov/pubmed/33509203
http://dx.doi.org/10.1186/s12967-021-02710-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845038/
https://www.ncbi.nlm.nih.gov/pubmed/33509203
http://dx.doi.org/10.1186/s12967-021-02710-y

Ejemplares similares